ONYX (#435)
Laufzeit: 01.01.2014 - 31.12.2015
imported
Kurzfassung
A randomized, open-label, phase III study of
Carfilzomib vs best supportive care in subjects with
relapsed and refractory Multiple Myeloma
Laufzeit: 01.01.2014 - 31.12.2015
A randomized, open-label, phase III study of
Carfilzomib vs best supportive care in subjects with
relapsed and refractory Multiple Myeloma
